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12th March 2015 
Smoking and osteoarthritis 
Dear Editor, 
Tobacco use is a major and rapidly increasing a public health issue in many parts of the 
Asia-Pacific region. Over half of the world’s smokers currently live in Asia and a recent 
review by Mackay et al
1
 highlighted that the prevalence of daily cigarette use in Asia 
ranges between 34.8% (67.0% males, 2.7% females) in Indonesia to 11.1 % (19.9% 
males, 3.0% females) in Hong Kong.
1
 Osteoarthritis (OA) is a common chronic disease 
in many Asia-Pacific countries. For example, the prevalence of symptomatic OA has 
been shown to vary from 5.1% to 20.8% in China.
2 Australian data suggests that 15% of 
the population self-report that they have arthritis, with most reporting that they have 
OA.
3
    
 
There have been recent headlines in the general and electronic media “Long-term 
smokers protected against osteoarthritis”4 which were prompted by an article published 
by Mnatzaganian et al
5
 using Australian data, and which demonstrated that being 
overweight and reporting physical activity increased the risk of elective total joint 
replacements (TJR) in a cohort of West Australian men, but a strong inverse dose-
response relationship existed between duration of smoking and TJR.  This dose-
response relationship did not appear to be influenced after controlling for age, co-
morbidity, weight, height, physical exercise, education or area-level socioeconomic 
status. However, the majority of TJRs in this study were undertaken in the private 
hospital setting (78.5%). Those treated in the public system were more likely to be 
socioeconomically disadvantaged and smoked more years
5
, and therefore more likely to 
have waited longer for the surgery.  
The authors did highlight that the study reinforced the risk of premature death 
associated with smoking, and  any beneficial effects of smoking were outweighed by 
many other health risks.
4,5
  Headlines such as this, however, can disrupt tobacco control 
messages that are provided by public health organisations and government health 




 recently undertook a meta-analysis to determine whether smoking was 
protective for OA. In total, 48 studies were examined.  While an overall negative 
association existed between OA and smoking, on subgroup analysis, this only remained 
for case-control studies, not in cross-sectional or cohort studies, underscoring the 
heterogeneous nature of the studies used included within the meta-analysis.  When 
analysed further, this negative association did not occur in the community setting, only 
in those recruited from a hospital setting, suggesting selection bias within these studies.  
In this case, meta-regression identified that smoking as a secondary exposure and the 
hospital setting (in which control subjects have smoking-related conditions) were the 
factors primarily associated with this negative association.  Therefore, the authors 
concluded that any protective effect of smoking in OA was likely to be false.
6
  A further 
meta-analysis by Pearce et al
7
 determined that the evidence for a protective effect of 
smoking on OA was not compelling.  Subgroup analyses demonstrated some negative 




Additionally, a dose response relationship between smoking and OA was not observed. 
It is, however, known that body weight is a major risk factor for OA
8
, and Hui et al
6
 
suggested that body weight may also confound a negative association identified 
between OA and smoking.  
 
The loss of cartilage of the knee has also been shown to be associated with smoking, 
particularly among those with a family history of OA.  Cartilage loss and defects are 
important aspects of OA and are related to severity 
9,10
, thus limiting these factors may 
reduce severity and the possibility of TJR. 
 
The headline mentioned, used TJR as a surrogate measure for the presence of OA. 
However, the interaction between OA and the provision of TJR is much more complex.  
In many countries, the number of elective total joint replacements are increasing, in 
China the increase is by approximately 15% annually, with the majority of replacements 
performed for OA.
11
 However, smoking increases the risk of short term postoperative 
complications with current smokers more likely to have infections at the site of surgery, 




In Australia, data from the Australian Orthopaedic Association National Joint 
Replacement Registry show that the majority (over 60%) of TJR are performed in 
private hospitals.
13
  This requires that patients to have access to private health insurance, 
so despite having  universal health care in Australia, there is likely to be inequity in TJR 
provision.   Generally those of higher socioeconomic status, have access to private 
hospital care with negligible waiting times. These are also patients with lower smoking 
levels and co-morbidities and thus are better surgical candidates. There are also issues 
that exist in countries such as China.  Firstly, there is a great variation between rural and 
urban areas in the proportion of people who receive TJR.  Those in under-resourced 
areas are unlikely to receive TJR.  There are  an insufficient number of surgeons to 
perform the surgery and rural areas also have a short supply of surgical facilities, thus 
many patients may fail to receive appropriate treatment.  Other issues include length of 
hospital stay and prosthesis size which may not be appropriate for the Chinese 
population.
11
 It is not hard to envisage that these issues are likely to occur in other Asia-
Pacific countries. 
 
The interaction between smoking duration and provision of elective joint replacement is 
a complex relationship between OA severity, socioeconomic status, health literacy, the 
willingness to undergo surgery, the provider’s perception of  surgical risk and the health 
system’s capacity to provide it in an appropriate and timely manner. 
 
By suggesting that smoking is protective for OA, a disservice may be done in terms of 
OA treatment and general health. Asia is a significant target for large tobacco 
companies and tobacco control is a major issue.
1
 OA already contributes a significant 
burden on society and the health care system.  The provision of mixed messages to the 
population is likely to negatively impact further on health care burden and OA cost.  A 
greater emphasis on access to services, education, improving health literacy and 
research is warranted in the musculoskeletal area in order to reduce health burden and 
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